SUSAN DOCK: Open Payments
NPI 1194296129 · MIDDLEBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 25 payments from 11 companies in 2025. Trend: 2023 $467 · 2024 $277 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $113 |
| Lilly USA, LLC | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Corcept Therapeutics | 3 | $47 |
| ABBVIE INC. | 2 | $42 |
| Phathom Pharmaceuticals, Inc. | 3 | $41 |
| Merck Sharp & Dohme LLC | 2 | $33 |
| Amgen Inc. | 2 | $31 |
| Soleno Therapeutics, Inc. | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
Products named: Ozempic, MOUNJARO, Korlym, VOQUEZNA, FARXIGA, QULIPTA, AIRSUPRA, VRAYLAR.
Industry payments across PA — which companies pay providers there.
